MedTrace Logo

Tissue Characterization and Primary Percutaneous Coronary Intervention Guidance Using Intravascular Ultrasound

NCT05007535 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2023-01-18

No results posted yet for this study

Summary

This prospective, single arm, observational cohort study is designed to assess the safety and efficacy of (high-definition) intravascular ultrasound (HD-IVUS) as guidance for primary percutaneous coronary intervention (PCI) and to assess culprit lesion plaque characteristics and thrombus morphology in patients with ST-elevation myocardial infarction (STEMI).

Objectives:

* To assess clinical outcomes after IVUS-guided primary PCI in STEMI patients.
* To assess IVUS-guided optimization in STEMI patients.
* To assess culprit lesion plaque characteristics in STEMI patients with HD-IVUS.
* To assess and quantify thrombus in STEMI patients with HD-IVUS.
* To explore HD-IVUS derived predictors for clinically relevant aspiration thrombectomy.

Conditions

  • ST Elevation Myocardial Infarction
  • Acute Myocardial Infarction
  • Coronary Artery Disease
  • Percutaneous Coronary Intervention
  • Intravascular Ultrasound
  • Thrombus

Sponsors & Collaborators

  • Acist Medical Systems

    collaborator INDUSTRY

  • MicroPort CRM

    collaborator INDUSTRY

  • Erasmus Medical Center

    lead OTHER

Principal Investigators

  • Joost Daemen, MD PhD · Erasmus Medical Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-11-10
Primary Completion
2023-02-02
Completion
2023-02-02

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05007535 on ClinicalTrials.gov